SCYNEXIS Inc SCYX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:30 AM EDT
5.88quote price arrow down-0.03 (-0.51%)
Volume
2,716
52 week range
4.20 - 10.25
Loading...
  • Open5.88
  • Day High5.94
  • Day Low5.88
  • Prev Close5.91
  • 52 Week High10.25
  • 52 Week High Date06/01/21
  • 52 Week Low4.20
  • 52 Week Low Date10/01/20

Key Stats

  • Market Cap136.53M
  • Shares Out23.22M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta2.22
  • YTD % Change-22.75

KEY STATS

  • Open5.88
  • Day High5.94
  • Day Low5.88
  • Prev Close5.91
  • 52 Week High10.25
  • 52 Week High Date06/01/21
  • 52 Week Low4.20
  • 52 Week Low Date10/01/20
  • Market Cap136.53M
  • Shares Out23.22M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta2.22
  • YTD % Change-22.75

RATIOS/PROFITABILITY

  • EPS (TTM)-3.47
  • P/E (TTM)-1.69
  • Fwd P/E (NTM)-2.42
  • EBITDA (MRQ)-45.808M
  • ROE (MRQ)-231.91%
  • Revenue (MRQ)12.05M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-371.95%
  • Debt To Equity (MRQ)124.91%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SCYNEXIS Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
SCYNEXIS, Inc. is a biotechnology company. The Company is developing its lead product candidate, ibrexafungerp, as a broad-spectrum, intravenous oral agent for multiple fungal indications in both the community and hospital settings. It has received the acceptance letter from the United States Food and Drug Administration (FDA) for the New Drug Application (NDA) for oral ibrexafungerp for the treatment of vulvovaginal candidiasis (VVC, also known as vaginal yeast infection)....
Pamela Kirby Ph.D.
Chairman
Marco Taglietti M.D.
President
Eric Francois
Chief Financial Officer
Scott Sukenick J.D.
General Counsel
Jim Maffezzoli
Vice President
Address
1 Evertrust Plz Fl 13
Jersey City, NJ
07302-3051
United States

Top Peers

SYMBOLLASTCHG%CHG
SCPH
scPharmaceuticals Inc
5.90-0.05-0.84%
CRMD
CorMedix Inc
4.69+0.01+0.21%
KALA
Kala Pharmaceuticals Inc
3.07UNCHUNCH
ACRX
AcelRx Pharmaceuticals Inc
1.00-0.02-1.96%
ZYNE
Zynerba Pharmaceuticals Inc
4.29-0.03-0.69%